Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model (Q78681889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Maria João Silva

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Maria G Boavida

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

Environmental and Molecular Mutagenesis

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

283-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

Cisplatin as an initiating agent in two-stage mouse skin carcinogenesis.

16 December 2019

cites work

1 reference

7 January 2021

Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II).

1 reference

7 January 2021

Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II).

1 reference

7 January 2021

Spectrum of cisplatin-induced mutations in Escherichia coli

1 reference

7 January 2021

Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli

1 reference

7 January 2021

Mutational spectra in transgenic animal research: data analysis and study design based upon the mutant or mutation frequency

1 reference

7 January 2021

Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene.

1 reference

7 January 2021

Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.

1 reference

7 January 2021

Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations.

1 reference

7 January 2021

Characterization of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.

1 reference

7 January 2021

Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine

1 reference

7 January 2021

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

7 January 2021

Cisplatin-DNA adduct formation in maternal and fetal rat tissues after transplacental cisplatin exposure.

1 reference

7 January 2021

Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure.

1 reference

7 January 2021

Application of galactose-sensitiveE.colistrains as selective hosts for LacZ−plasmids

1 reference

7 January 2021

Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model

1 reference

7 January 2021

In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic

1 reference

7 January 2021

Distribution of spontaneous CpG-associated G:C --> A:T mutations in the lacZ gene of Muta mice: effects of CpG methylation, the sequence context of CpG sites, and severity of mutations on the activity of the lacZ gene product

1 reference

7 January 2021

Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats

1 reference

7 January 2021

DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene.

1 reference

7 January 2021

Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity

1 reference

7 January 2021

Transgenic Animal Models for Detection of In Vivo Mutations

1 reference

7 January 2021

Analysis of mutations induced in the SUP4-o gene of Saccharomyces cerevisiae by cis-diammine dichloroplatinum(II).

1 reference

7 January 2021

Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene

1 reference

7 January 2021

RuvAB acts at arrested replication forks

1 reference

7 January 2021

Treatment-Associated Leukemia Following Testicular Cancer

1 reference

7 January 2021

Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

1 reference

7 January 2021

Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).

1 reference

7 January 2021

Identifiers

DOI

10.1002/EM.10118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12489119%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference